Increased PTCH2 mRNA expression correlates with poorer overall survival in muscle-invasive BC [37] and a functional link of PTCH2 in regulating the activation of Dhh pathway has been suggested [41]; moreover enhanced Dhh expression was associated with invasive prostate and bladder cancers and hormone-refractory behaviour [42]. This evidence concerns the gene DHH and urinary bladder cancer.